Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).

Diagnosis of Alzheimer's disease (AD) can be performed with the assistance of amyloid imaging. The current method relies on positron emission tomography (PET), which is expensive and exposes people to radiation, undesirable features for a population screening method. Magnetic resonance imaging (MRI) is cheaper and is not radioactive. Our approach uses magnetic nanoparticles (MNPs) made of superparamagnetic iron oxide (SPIO) conjugated with curcumin, a natural compound that specifically binds to amyloid plaques. Coating of curcumin-conjugated MNPs with polyethylene glycol-polylactic acid block copolymer and polyvinylpyrrolidone by antisolvent precipitation in a multi-inlet vortex mixer produces stable and biocompatible curcumin magnetic nanoparticles (Cur-MNPs) with mean diameter <100 nm. These nanoparticles were visualized by transmission electron microscopy and atomic force microscopy, and their structure and chemistry were further characterized by X-ray diffraction, thermogravimetric analysis, X-ray photoelectron spectroscopy, time-of-flight secondary ion mass spectrometry, and Fourier transform infrared spectroscopy. Cur-MNPs exhibited no cytotoxicity in either Madin-Darby canine kidney (MDCK) or differentiated human neuroblastoma cells (SH-SY5Y). The Papp of Cur-MNPs was 1.03 × 10(-6) cm/s in an in vitro blood-brain barrier (BBB) model. Amyloid plaques could be visualized in ex vivo T2*-weighted magnetic resonance imaging (MRI) of Tg2576 mouse brains after injection of Cur-MNPs, and no plaques could be found in non-transgenic mice. Immunohistochemical examination of the mouse brains revealed that Cur-MNPs were co-localized with amyloid plaques. Thus, Cur-MNPs have the potential for non-invasive diagnosis of AD using MRI.

[1]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[2]  P. Eu,et al.  Development and use of iron oxide nanoparticles ( Part 1 ) : Synthesis of iron oxide nanoparticles for MRI , 2010 .

[3]  Shouhu Xuan,et al.  Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research , 2013, Current pharmaceutical design.

[4]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[5]  V. Libri,et al.  PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. , 2007, Brain : a journal of neurology.

[6]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[7]  M. Rahimi,et al.  Development of multiple-layer polymeric particles for targeted and controlled drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[8]  Gordon L. Amidon,et al.  Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size , 1996, Pharmaceutical Research.

[9]  U. Häfeli,et al.  Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy , 2004 .

[10]  Yi-Xiang J. Wang.  Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. , 2011, Quantitative imaging in medicine and surgery.

[11]  J. Provenzale,et al.  Uses of Nanoparticles for Central Nervous System Imaging and Therapy , 2009, American Journal of Neuroradiology.

[12]  Thomas Wisniewski,et al.  Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.

[13]  Thomas Wisniewski,et al.  A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice , 2008, Neurobiology of Aging.

[14]  Tim G St Pierre,et al.  Encapsulation and sustained release of curcumin using superparamagnetic silica reservoirs. , 2009, Chemistry.

[15]  André R Studart,et al.  Colloidal stabilization of nanoparticles in concentrated suspensions. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[16]  J. Bulte,et al.  Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation , 1998, Journal of Neuroscience Research.

[17]  Antonello Barresi,et al.  CFD Modelling of Nano-Particle Precipitation in Confined Impinging Jet Reactors , 2006 .

[18]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[19]  Seifollah Nasrazadani,et al.  Quantitative analysis of iron oxides using Fourier transform infrared spectrophotometry , 2008 .

[20]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[21]  A. Laskin,et al.  TOF-SIMS analysis of sea salt particles: imaging and depth profiling in the discovery of an unrecognized mechanism for pH buffering , 2004 .

[22]  N. Karak,et al.  'Poly(ethylene glycol)-magnetic nanoparticles-curcumin' trio: directed morphogenesis and synergistic free-radical scavenging. , 2010, Colloids and surfaces. B, Biointerfaces.

[23]  Anansa S. Ahmed,et al.  Synthesis, Characterization and In Vitro Study of Curcumin-Functionalized Citric Acid-Capped Magnetic (CCF) Nanoparticles as Drug Delivery Agents in Cancer , 2011 .

[24]  N. Sousa,et al.  Blood–brain-barriers in aging and in Alzheimer’s disease , 2013, Molecular Neurodegeneration.

[25]  Takashi Morihara,et al.  Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.

[26]  R. Dijkhuizen,et al.  MRI of Monocyte Infiltration in an Animal Model of Neuroinflammation Using SPIO-Labeled Monocytes or Free USPIO , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  A. Chow,et al.  Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice , 2012, The AAPS Journal.

[28]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[29]  Ning Gu,et al.  Preparation and characterization of magnetite nanoparticles coated by amino silane , 2003 .

[30]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[31]  S. Davis,et al.  Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.

[32]  J. Gestwicki,et al.  Structure–activity Relationships of Amyloid Beta‐aggregation Inhibitors Based on Curcumin: Influence of Linker Length and Flexibility , 2007, Chemical biology & drug design.

[33]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[34]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[35]  Dar-Bin Shieh,et al.  Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications. , 2005, Biomaterials.

[36]  Thomas Wisniewski,et al.  Magnetic resonance imaging of amyloid plaques in transgenic mice. , 2005, Methods in molecular biology.

[37]  Dar-Bin Shieh,et al.  Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents. , 2005, Biomaterials.

[38]  Thomas Wisniewski,et al.  Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging , 2013, PloS one.

[39]  W. Kreyling,et al.  TOF-SIMS characterisation of spark-generated nanoparticles made from pairs of Ir-Ir and Ir-C electrodes , 2006 .

[40]  Weihong Tan,et al.  Synthesis and Characterization of Silica-Coated Iron Oxide Nanoparticles in Microemulsion: The Effect of Nonionic Surfactants , 2001 .

[41]  Pedro Rosa-Neto,et al.  Olfactory identification as a potential marker of presymptomatic Alzheimer's disease , 2013, Alzheimer's & Dementia.

[42]  F. Aqil,et al.  Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention , 2011, Cancer Prevention Research.

[43]  Sourav Das,et al.  Preferential and Enhanced Adsorption of Different Dyes on Iron Oxide Nanoparticles: A Comparative Study , 2011 .

[44]  D. R. Baer,et al.  Application of surface chemical analysis tools for characterization of nanoparticles , 2010, Analytical and bioanalytical chemistry.

[45]  E. Sigurdsson,et al.  In vivo magnetic resonance imaging of amyloid-β plaques in mice. , 2012, Methods in molecular biology.

[46]  Murali M. Yallapu,et al.  Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. , 2011, Biomaterials.

[47]  Ajay Kumar Gupta,et al.  Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. , 2005, Biomaterials.

[48]  P. Kwan,et al.  In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P‐glycoprotein , 2011, Epilepsia.

[49]  Eun Kyoung Ryu,et al.  Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. , 2006, Journal of medicinal chemistry.

[50]  S. DeKosky,et al.  Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain , 2005, The Journal of Neuroscience.

[51]  M. Salvatore,et al.  Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. , 2014, Quantitative imaging in medicine and surgery.

[52]  Lucienne Juillerat-Jeanneret,et al.  Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. , 2012, Nanomedicine.

[53]  D. Yanagisawa,et al.  Amyloid imaging using high-field magnetic resonance. , 2010, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[54]  Clifford R. Jack,et al.  Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration , 2014, Neurology.

[55]  P. Zhou,et al.  Interaction of curcumin with Zn(II) and Cu(II) ions based on experiment and theoretical calculation , 2010 .

[56]  M. Rudin,et al.  Detecting amyloid-β plaques in Alzheimer's disease. , 2011, Methods in molecular biology.

[57]  Liang Feng,et al.  Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. , 2011, Biomaterials.

[58]  K. Nicolay,et al.  Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. , 2004, Brain : a journal of neurology.

[59]  L. Baum,et al.  Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. , 2004, Journal of Alzheimer's disease : JAD.

[60]  H. Matsuda,et al.  Molecular neuroimaging in Alzheimer's disease. , 2012, Neuroimaging clinics of North America.

[61]  A. Basbaum,et al.  Loss of function genetic screens reveal MTGR1 as an intracellular repressor of β1 integrin-dependent neurite outgrowth , 2009, Journal of Neuroscience Methods.

[62]  Fazli Wahid,et al.  Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials , 2010, Archiv der Pharmazie.

[63]  N. Ferris,et al.  Development and use of iron oxide nanoparticles (part 2): The application of iron oxide contrast agents in MRI , 2010 .

[64]  Ling Ye,et al.  The blood-brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain. , 2010, Biochemical and biophysical research communications.

[65]  Bill Wilson,et al.  Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort , 2012, Alzheimer's & Dementia.

[66]  Marie-Hélène Dufresne,et al.  Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[67]  V. Mok,et al.  Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. , 2008, Journal of clinical psychopharmacology.

[68]  Patrick Couvreur,et al.  Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat , 2002, The European journal of neuroscience.

[69]  D. Luo,et al.  Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.

[70]  S. Jee,et al.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.

[71]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[72]  Ying Liu,et al.  CFD predictions for chemical processing in a confined impinging‐jets reactor , 2006 .

[73]  P. Couvreur,et al.  Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.

[74]  Mansoor M. Amiji,et al.  Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.

[75]  A Van der Linden,et al.  Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease , 2005, Magnetic resonance in medicine.

[76]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[77]  P. Sanguansri,et al.  Impact of oil type on nanoemulsion formation and Ostwald ripening stability. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[78]  W. Bascom,et al.  Effect of Plasma Treatment on the Adhesion of Carbon Fibers to Thermoplastic Polymers , 1991 .

[79]  H. Kikkawa,et al.  Synthesis of fine magnetite powder using reverse coprecipitation method and its heating properties by applying AC magnetic field , 2005 .

[80]  Antonello Barresi,et al.  CFD modelling and scale-up of Confined Impinging Jet Reactors , 2007 .

[81]  Thomas Wisniewski,et al.  Detection of amyloid plaques targeted by USPIO-Aβ1–42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging , 2011, NeuroImage.

[82]  Clifford R Jack,et al.  In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice , 2005, The Journal of Neuroscience.

[83]  T. Tran,et al.  Nanosized magnetofluorescent Fe3O4-curcumin conjugate for multimodal monitoring and drug targeting , 2010 .

[84]  Thomas Wisniewski,et al.  In Vivo Magnetic Resonance of Amyloid Plaques in Alzheimer’s Disease Model Mice , 2004 .

[85]  R. Coleman,et al.  Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. , 2003, Radiology.

[86]  R. Castellani,et al.  The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery. , 2012, International review of neurobiology.

[87]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[88]  I. Hidalgo,et al.  Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. , 2005, International journal of pharmaceutics.

[89]  W. Thies,et al.  2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.

[90]  Mary Mittelman,et al.  World Alzheimer Report 2012: Overcoming the Stigma of Dementia , 2012 .

[91]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[92]  Clifford R. Jack,et al.  MR Microimaging of amyloid plaques in Alzheimer’s disease transgenic mice , 2008, European Journal of Nuclear Medicine and Molecular Imaging.